These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29886291)

  • 1. Estimation of Severity of Moyamoya Disease with [
    Roder C; Bürkle E; Ebner FH; Tatagiba M; Ernemann U; Buck A; Meyer PT; Khan N
    World Neurosurg; 2018 Sep; 117():e75-e81. PubMed ID: 29886291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative H2[(15)O]-PET in Pediatric Moyamoya Disease: Evaluating Perfusion before and after Cerebral Revascularization.
    Kuhn FP; Warnock G; Schweingruber T; Sommerauer M; Buck A; Khan N
    J Stroke Cerebrovasc Dis; 2015 May; 24(5):965-71. PubMed ID: 25813061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypercapnic BOLD MRI compared to H
    Hauser TK; Seeger A; Bender B; Klose U; Thurow J; Ernemann U; Tatagiba M; Meyer PT; Khan N; Roder C
    Neuroimage Clin; 2019; 22():101713. PubMed ID: 30743136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative cerebral perfusion imaging in children and young adults with Moyamoya disease: comparison of arterial spin-labeling-MRI and H(2)[(15)O]-PET.
    Goetti R; Warnock G; Kuhn FP; Guggenberger R; O'Gorman R; Buck A; Khan N; Scheer I
    AJNR Am J Neuroradiol; 2014 May; 35(5):1022-8. PubMed ID: 24335546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterial spin-labeling MR imaging in Moyamoya disease compared with clinical assessments and other MR imaging findings.
    Noguchi T; Kawashima M; Nishihara M; Hirai T; Matsushima T; Irie H
    Eur J Radiol; 2013 Dec; 82(12):e840-7. PubMed ID: 24055185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychological impairment in adults with moyamoya angiopathy: preoperative assessment and correlation to MRI and H
    Roder C; Haas P; Fudali M; Milian M; Ernemann U; Meyer PT; Tatagiba M; Khan N
    Neurosurg Rev; 2020 Dec; 43(6):1615-1622. PubMed ID: 31728848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying Hypoperfusion in Moyamoya Disease With Arterial Spin Labeling and an [
    Fan AP; Khalighi MM; Guo J; Ishii Y; Rosenberg J; Wardak M; Park JH; Shen B; Holley D; Gandhi H; Haywood T; Singh P; Steinberg GK; Chin FT; Zaharchuk G
    Stroke; 2019 Feb; 50(2):373-380. PubMed ID: 30636572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life impairment in adult Moyamoya patients-preoperative neuropsychological assessment and correlation to MRI and H
    Haas P; Fudali M; Wang SS; Hurth H; Hauser TK; Ernemann U; Tatagiba M; Khan N; Roder C
    Neurosurg Rev; 2022 Apr; 45(2):1533-1541. PubMed ID: 34671887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal Reproducibility of CO2-Triggered BOLD MRI for the Hemodynamic Evaluation of Adult Patients with Moyamoya Angiopathy.
    Roder C; Klose U; Hurth H; Brendle C; Tatagiba M; Ernemann U; Khan N; Hauser TK
    Cerebrovasc Dis; 2021; 50(3):332-338. PubMed ID: 33556937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic changes after H(2) 15O-positron emission tomography with acetazolamide in a patient with moyamoya disease: case report and review of previous cases.
    Muroi C; Yonekawa Y; Khan N; Pangalu A; Keller E
    J Neurosurg Anesthesiol; 2003 Apr; 15(2):131-9. PubMed ID: 12657999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of central benzodiazepine receptor binding potential/cerebral blood flow SPECT imaging for detecting misery perfusion in patients with unilateral major cerebral artery occlusive diseases: comparison with cerebrovascular reactivity to acetazolamide and cerebral blood flow SPECT imaging.
    Kuroda H; Ogasawara K; Suzuki T; Chida K; Aso K; Kobayashi M; Yoshida K; Terasaki K; Fujiwara S; Kubo Y; Ogawa A
    Clin Nucl Med; 2012 Mar; 37(3):235-40. PubMed ID: 22310248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique Angiographic Appearances of Moyamoya Disease Detected with 3-Dimensional Rotational Digital Subtraction Angiography Imaging Showing the Hemodynamic Status.
    Karakama J; Nariai T; Hara S; Hayashi S; Sumita K; Inaji M; Tanaka Y; Wagatsuma K; Ishii K; Nemoto S; Maehara T
    J Stroke Cerebrovasc Dis; 2018 Aug; 27(8):2147-2157. PubMed ID: 29653803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arterial spin-labeling magnetic resonance imaging after revascularization of moyamoya disease.
    Sugino T; Mikami T; Miyata K; Suzuki K; Houkin K; Mikuni N
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):811-6. PubMed ID: 22721824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience of treatment of moyamoya disease at the Clinic of Neurosurgery of Kaunas University of Medicine.
    Marcinkevicius E; Liutkus D; Gvazdaitis A
    Medicina (Kaunas); 2006; 42(2):130-6. PubMed ID: 16528129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring Cerebral Blood Flow in Moyamoya Angiopathy by Quantitative Magnetic Resonance Angiography Noninvasive Optimal Vessel Analysis.
    Khan N; Lober RM; Ostergren L; Petralia J; Bell-Stephens T; Navarro R; Feroze A; Steinberg GK
    Neurosurgery; 2017 Dec; 81(6):921-927. PubMed ID: 28204602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective surgical revascularization improves cerebral hemodynamics and resolves headache in pediatric Moyamoya disease.
    Kawabori M; Kuroda S; Nakayama N; Hirata K; Shiga T; Houkin K; Tamaki N
    World Neurosurg; 2013 Nov; 80(5):612-9. PubMed ID: 23022638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative assessment of cerebral hemodynamics using perfusion-weighted MRI in patients with major cerebral artery occlusive disease: comparison with positron emission tomography.
    Endo H; Inoue T; Ogasawara K; Fukuda T; Kanbara Y; Ogawa A
    Stroke; 2006 Feb; 37(2):388-92. PubMed ID: 16373637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constant-infusion H(2)15O PET and acetazolamide challenge in the assessment of cerebral perfusion status.
    Weber B; Westera G; Treyer V; Burger C; Khan N; Buck A
    J Nucl Med; 2004 Aug; 45(8):1344-50. PubMed ID: 15299060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unraveling Specific Brain Microstructural Damage in Moyamoya Disease Using Diffusion Magnetic Resonance Imaging and Positron Emission Tomography.
    Hara S; Hori M; Ueda R; Hayashi S; Inaji M; Tanaka Y; Maehara T; Ishii K; Aoki S; Nariai T
    J Stroke Cerebrovasc Dis; 2019 Apr; 28(4):1113-1125. PubMed ID: 30679013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging of Moyamoya Disease and Moyamoya Syndrome: Current Status.
    Li J; Jin M; Sun X; Li J; Liu Y; Xi Y; Wang Q; Zhao W; Huang Y
    J Comput Assist Tomogr; 2019; 43(2):257-263. PubMed ID: 30589721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.